Godrej Agrovet Q4 FY26: Profit Jumps 48% as Animal Feed & Palm Oil Fire on All Cylinders

Godrej Agrovet Limited (GAVL) just dropped its audited FY26 results, and if you were expecting a sleepy agri-commodity performance, you clearly haven’t been paying attention. The company clocked a 9.33% growth in quarterly sales and a massive 48.1% surge in PAT, proving that being the “backbone of the farmer” is actually a pretty lucrative gig when you know how to squeeze margins out of a cow’s diet and a palm tree’s fruit.

While the broader market struggles with erratic monsoons and global supply chain hiccups, GAVL has managed to post a consolidated revenue of ₹10,233 crore for the full year. This isn’t just luck; it’s a diversified masterclass. When the dairy business gets kicked in the teeth by milk inflation, the palm oil segment steps up to carry the team. It’s a financial tag-team match where the referee (the government) keeps changing the rules, yet Godrej finds a way to win.

1. At a Glance – The Agri-Conglomerate Machine

Godrej Agrovet is essentially five different companies wearing one trench coat. They are the biggest organized player in India’s Animal Feed sector, the largest Oil Palm processor in the country, and a serious contender in Crop Protection, Dairy, and Poultry. If a farmer touches it, Godrej probably sold it to them or bought it from them.

In Q4 FY26, the company reported a Net Profit of ₹104.85 crore, up from ₹70.78 crore in the same period last year. That is a 48% YoY jump that smells like efficiency and sounds like a cash register. The annual dividend of ₹11 per share is just the cherry on top for those who enjoy a yield of 1.84% while waiting for the growth story to fully bake.

The real story here is the margin expansion. For a company that deals in commodities like soybean meal and crude palm oil—where prices move faster than a tech bro’s opinion on AI—maintaining an Operating Profit Margin (OPM) of 8.44% is an Olympian feat. Management has spent the last year pivoting away from “trading” businesses (like selling live birds) towards “branded” businesses (like selling Yummiez nuggets). This shift from B2B to B2C is where the real valuation re-rating lives.

If you look at the numbers, GAVL is currently trading at a P/E of 23.2, which is basically the industry median. You aren’t paying a premium for the Godrej brand yet, despite the fact that they own 30% market share in the Oil Palm segment. With the recent change in management—Sunil Kataria taking the reins and Nadir Godrej retiring—the street is betting on a leaner, meaner, and more aggressive Godrej.

2. Introduction – The Transition to Value

For years, Godrej Agrovet was viewed as a proxy for the Indian monsoon. If it rained, the stock went up; if it didn’t, investors cried. However, the FY26 data suggests the “monsoon-dependency” is being diluted by sheer industrial scale and R&D. The company operates 60 manufacturing units and works with over 11,000 palm oil farmers.

The introduction of Sunil Kataria as CEO & MD (formerly of Godrej Consumer Products) is the biggest “tell” in the room. You don’t bring in a consumer-goods specialist to run a farm unless you intend to turn that farm into a brand-building powerhouse. We are seeing a fundamental shift in how this company allocates capital—moving away from low-margin animal feed volumes towards high-tech CDMO (Contract Development and Manufacturing) in their subsidiary, Astec LifeSciences.

Despite a 22.6% drop in stock price over the last year, the fundamentals are screaming a different tune. The Return on Equity (ROE) stands at 22.4% and ROCE at 20.2%. In the world of high-credibility finance, those are “sexy” numbers. The market might be punishing them for the debt increase, but as we’ll see in the balance sheet section, that debt was used to buy out the rest of their Dairy subsidiary. They are consolidating the empire.

3. Business Model – WTF Do They Even Do?

GAVL is the ultimate “Pick and Shovel” play for the Indian food story. They don’t just sell one thing; they own the entire value chain.

• Animal Feed (47% Revenue): They make high-quality “protein snacks” for cows, chickens, and fish. It’s a volume game. They moved 1.5 million metric tonnes of feed this year. Think of them as the Michelin-star chef for livestock.
• Vegetable Oil (14% Revenue): They are the Palm Oil kings of India. They don’t just process it; they manage the plantations. With the government’s push for “Atmanirbhar” oil, GAVL is sitting on a goldmine of 2,00,000 hectares of potential plantation area.
• Crop Protection (13% Revenue): They sell the “medicines” (insecticides and fungicides) that keep crops from dying. This is high-margin stuff, especially the in-house molecules like Hitweed.
• Dairy & Poultry (26% Combined): They sell milk under the Jersey brand and chicken under Real Good Chicken. This is where they are trying to prove they can play in the FMCG big leagues.

Essentially, Godrej Agrovet is a diversified hedge fund of agriculture. If one segment fails, another bails it out. It’s a beautiful, chaotic, and highly scientific machine designed to extract value from the soil.

4. Financials Overview

Let’s look at the “Quarterly Scorecard” to see if management actually delivered or if they were just talking to the cows.

Quarterly Performance (Consolidated)

Figures in ₹ Crores

Annualised EPS Calculation:

Since this is the Q4 (March) result, we use the full-year EPS provided in the data.

Full Year FY26 EPS = ₹24.58

Current Market Price = ₹596

Calculated P/E = 24.2x (Matches the data dump closely).

Witty Commentary:

Management “walked the talk” on the bottom line but stumbled slightly on the